Literature DB >> 9776330

Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards.

H C Cochrane1, A G Marson, G A Baker, D W Chadwick.   

Abstract

PURPOSE: To systematically review the methodology and use of neuropsychological tests in randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) in patients with epilepsy.
METHODS: Trial reports were found by searching Medline 1966-1996 and searching through journals by hand. Inclusion and exclusion criteria were applied, and methodological and neuropsychological test data was extracted by using a proforma.
RESULTS: 43 reports met our inclusion criteria, representing 40 RCTs. as three RCTs had generated two reports. Twenty-two were actively controlled, and 18 were placebo-controlled studies. Reporting of basic methods such as randomization method was poor. There has been no uniform approach to the use of neuropsychological tests, and a total of 87 has been used. The Stroop Colour Word Test and the Finger Tapping Test were most commonly used, at 13 times each, but were not used or reported in a uniform manner.
CONCLUSIONS: Poor reporting of methods and the use of a plethora of neuropsychological tests create great difficulties for anyone wishing to make sense of currently available data. If we are better to understand the neuropsychological effects of AEDs, a more rational approach is needed, for which recommendations are made.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776330     DOI: 10.1111/j.1528-1157.1998.tb01295.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Tiagabine add-on for drug-resistant partial epilepsy.

Authors:  Jennifer Pulman; Anthony G Marson; Jane L Hutton
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy.

Authors:  Sergio M Castillo; Dieter B Schmidt; Sarah White; Arif Shukralla
Journal:  Cochrane Database Syst Rev       Date:  2016-11-15

Review 3.  Tiagabine add-on therapy for drug-resistant focal epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

Review 4.  Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents.

Authors:  Lars Brunbech; Anne Sabers
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Levetiracetam add-on for drug-resistant focal epilepsy.

Authors:  Gashirai K Mbizvo; Bharath Chandrasekar; Sarah J Nevitt; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-06-30

6.  Vigabatrin add-on therapy for drug-resistant focal epilepsy.

Authors:  Rebecca Bresnahan; Myrsini Gianatsi; Melissa J Maguire; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

Review 7.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 8.  Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Authors:  Gashirai K Mbizvo; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 9.  Tiagabine add-on for drug-resistant partial epilepsy.

Authors:  Jennifer Pulman; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-02-05

10.  Oxcarbazepine add-on for drug-resistant focal epilepsy.

Authors:  Rebecca Bresnahan; Margaret Atim-Oluk; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.